Copyright
©The Author(s) 2019.
World J Gastroenterol. Oct 14, 2019; 25(38): 5814-5825
Published online Oct 14, 2019. doi: 10.3748/wjg.v25.i38.5814
Published online Oct 14, 2019. doi: 10.3748/wjg.v25.i38.5814
Figure 4 Mechanistic role of Wnt1-inducible signaling pathway protein 1 in gastric cancer cells.
A and B: Silencing of Wnt1-inducible signaling pathway protein 1 (WISP1) has effects on cell viability of MKN45 and AGS cells; C: Silencing of WISP1 results in a significant decrease in the IC50 value; D and E: Silencing of WISP1 results in γH2AX overexpression and XRCC1 downregulation in MKN45 and AGS cells. NC: The matching scramble control siRNAs were transfected into cell lines as normal controls; RNAi: The siRNAs were transfected into cell lines as RNA interference; WISP1: Wnt1-inducible signaling pathway protein 1.
- Citation: Zhang LH, Wang Y, Fan QQ, Liu YK, Li LH, Qi XW, Mao Y, Hua D. Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer. World J Gastroenterol 2019; 25(38): 5814-5825
- URL: https://www.wjgnet.com/1007-9327/full/v25/i38/5814.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i38.5814